PEDIATRICS Vol. 114 No. 2 August 2004, pp. 521-522
SUPPLEMENT ARTICLE
THE EFFECT OF HYDROLYZED COWS MILK FORMULA FOR ALLERGY PREVENTION IN THE FIRST YEAR OF LIFE: THE GERMAN INFANT NUTRITIONAL INTERVENTION STUDY, A RANDOMIZED, DOUBLE-BLIND TRIAL
James R. Banks, MD
Arnold, MD
von Berg A, Koletzko S, Grubl A, et al. J Allergy Clin Immunol.2003;111:533540
Feeding extensively or partially hydrolyzed formulas to infantsmight reduce their risk of developing allergic disorders, butthe scope of benefit remains unclear. The authors sought toassess the preventive effect of different hydrolyzed formulasversus cows milk in a prospective study among high-riskinfants.
Infants were randomly assigned at birth, in a blinded manner,to 1 of 4 formulas, ie, cows milk formula (CMF), partiallyhydrolyzed whey formula, extensively hydrolyzed whey formula,or extensively hydrolyzed casein formula (eHF-C). However, allmothers were encouraged to breastfeed exclusively for the first4 to 6 months. Study formula was provided for the first 6 months.Avoidance of solid foods for the first 4 months was advised,with subsequent avoidance of cows milk, eggs, soy, fish,peanuts, nuts, tomatoes, and citrus fruits during the first1 year. Mothers maintained diaries of milk sources for the first6 months. Children were examined at 1, 4, 8, and 12 months ofage. The primary end point at 1 year of age was the presenceof allergic manifestation, which was defined as atopic dermatitis(AD), gastrointestinal manifestations of food allergy, allergicurticaria, or a combination of these. Both immunoglobulin E-mediatedand nonimmunoglobulin E-mediated reactions were consideredfor gastrointestinal manifestations of food allergy, and symptomsneeded to disappear with elimination of the suspected formulaand to recur with challenge for diagnosis. Asthma and allergicrhinitis were excluded from consideration as allergic manifestations,because diagnoses are usually difficult to establish in thefirst 1 year of life.
Of the 2252 infants enrolled, 889 were exclusively breastfedfor the first 4 months, of whom 865 were monitored for the entirestudy period. Of the 1249 infants assigned to a study formula,418 left before completion of enrollment data, left thereafter,or were excluded because of noncompliance. A total of 945 infantswho adhered to the study formula protocol for the entire 12months remained. Among the hydrolyzed formulas, only eHF-C wasassociated with a significant decrease in allergic manifestations,compared with CMF. However, when the outcome of AD was analyzedspecifically, both eHF-C and partially hydrolyzed whey formulawere associated with more favorable outcomes, compared withCMF. A family history of AD was associated with lesser benefit,with only eHF-C approaching statistical significance, comparedwith CMF (P = .077). The results for exclusively breastfed infantswere not included in the analysis, because it was not possibleto randomize to breastfeeding for ethical reasons and motherswho chose to nurse differed from the mothers of formula-fedinfants with respect to important variables, including greaterfamily prevalence of AD, less smoking, and fewer pets.
The expression of allergic diseases in the first 1 year of lifeis favorably modified by the use of less allergenic milk sources,especially in the absence of a family history of AD. Individualhydrolysate formulas must be studied more extensively in thisrole.
The findings of this study are consistent with various observationson the role of hypoallergenic formulas in ameliorating allergicdisease early in life. Of course, this study was not designedto look beyond the first 1 year of life, and most evidence todate suggests that the protective benefits of such early foodallergen avoidance are limited to AD and immunologic reactionsto food proteins, without significant effects on lifetime risksfor asthma and allergic rhinitis.